Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer-Reference-Cited by-同舟云学术

Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer

Published:2016-09-30 Issue:3 Volume:21 Page:187-193
ISSN:2288-3649
Container-title:Journal of Cancer Prevention
language:en
Short-container-title:J Cancer Prev

Author:

Yoon Ho Il¹,Kwon Oh-Ran²,Kang Kyung Nam²,Shin Yong Sung²,Shin Ho Sang²,Yeon Eun Hee²,Kwon Keon Young³,Hwang Ilseon³,Jeon Yoon Kyung⁴,Kim Yongdai⁵,Kim Chul Woo²⁴

Affiliation:

1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea

2. BioInfra, Inc., Seoul, Korea

3. Department of Pathology, Korea Regional Bank, Keimyung University School of Medicine, Daegu, Korea

4. Department of Pathology, Seoul National University College of Medicine, Seoul, Korea

5. Department of Statistics, College of Natural Science, Seoul National University, Seoul, Korea

Publisher

Korean Society of Cancer Prevention

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://pdf.medrang.co.kr/Jkacp2/021/Jkacp021-03-08.pdf

Reference28 articles.

1. Aberle, DR, Adams, AM, Berg, CD, Black, WC, Clapp, JD, and National Lung Screening Trial Research Team (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med.365, 395-409.

2. Quaife, SL, Ruparel, M, Beeken, RJ, McEwen, A, Isitt, J, and Nolan, G (2016). The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients. BMC Cancer.16, 281.

3. Patz, EF, Greco, E, Gatsonis, C, Pinsky, P, Kramer, BS, and Aberle, DR (2016). Lung cancer incidence and mortality in national lung screening trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol.17, 590-9.

4. Cuca, LE, Coy, ED, Alarcón, MA, Fernández, A, and Aristizábal, FA (2011). Cytotoxic effect of some natural compounds isolated from Lauraceae plants and synthetic derivatives. Biomedica.31, 335-43.

5. Zhao, W, Yu, H, Han, Z, Gao, N, Xue, J, and Wang, Y (2015). Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer. Int J Clin Exp Pathol.8, 9506-11.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning computational model to predict lung cancer using electronic medical records;Cancer Epidemiology;2024-10

2. Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios are Predictors of Lung Malignancy;Journal of Biomedicine and Translational Research;2024-04-19

3. Comparative Serum Proteome Profiling of Canine Benign Prostatic Hyperplasia before and after Castration;Animals;2023-12-14

4. The Role of Apolipoproteins in the Commonest Cancers: A Review;Cancers;2023-11-24

5. Integrated models of blood protein and metabolite enhance the diagnostic accuracy for Non-Small Cell Lung Cancer;Biomarker Research;2023-07-20